Author Topic: Steve Jobs declared Thermonuclear war on Google , Meeting Obama and his Health  (Read 740 times)

NarcissisticDeity

  • Getbig V
  • *****
  • Posts: 83359
  • Go back to making jewelry and cakes with your girl
On Android


"I will spend my last dying breath if I need to, and I will spend every penny of Apple's $40 billion in the bank, to right this wrong," Jobs said. "I'm going to destroy Android, because it's a stolen product. I'm willing to go thermonuclear war on this."

Jobs used an expletive to describe Android and Google Docs, Google's Internet-based word processing program. In a subsequent meeting with Schmidt at a Palo Alto, Calif., cafe, Jobs told Schmidt that he wasn't interested in settling the lawsuit, the book says.

"I don't want your money. If you offer me $5 billion, I won't want it. I've got plenty of money. I want you to stop using our ideas in Android, that's all I want."


On meeting Obama

Though his wife told him that Obama "was really psyched to meet with you," Jobs insisted on the personal invitation, and the standoff lasted for five days. When he finally relented and they met at the Westin San Francisco Airport, Jobs was characteristically blunt. He seemed to have transformed from a liberal into a conservative.

"You're headed for a one-term presidency," he told Obama at the start of their meeting, insisting that the administration needed to be more business-friendly. As an example, Jobs described the ease with which companies can build factories in China compared to the United States, where "regulations and unnecessary costs" make it difficult for them.


on his Health , for 9 months he initially put off getting treatment , he might have lived if he didn't

Although he spurned it at first, once he'd given in to mainstream medicine, Jobs spared no expense—he was one of the few people ever to have a personal DNA sequence compiled on their cancerous and normal DNA, the NYT says:

The DNA sequencing that Mr. Jobs ultimately went through was done by a collaboration of teams at Stanford, Johns Hopkins, Harvard and the Broad Institute of MIT. The sequencing, Mr. Isaacson writes, allowed doctors to tailor drugs and target them to the defective molecular pathways.